139
Participants
Start Date
January 7, 2021
Primary Completion Date
October 12, 2022
Study Completion Date
October 12, 2022
0.02% Betamethasone Sodium Phosphate
topical corticosteroid solution
0.04% Betamethasone Sodium Phosphate
topical corticosteroid solution
Placebo
topical vehicle solution
Alterman, Modi & Wolter, Poughkeepsie
Scott & Christie and Associates, PC, Cranberry Township
Bucci Laser Vision, Wilkes-Barre
Coastal Research Associates, LLC, Roswell
Eye Center of North Florida PA, Panama City
Blue Ocean Clinical Research (The Macula Center), Clearwater
Eye Associates of Fort Myers, Fort Myers
The Eye Associates of Manatee, Bradenton
Trinity Research Group, Dothan
West TN EyeCare dba Toyos Clinic, Nashville
Total Eye Care, PA, Memphis
Kentucky Eye Institute, Lexington
Cincinnati Eye Institute, Edgewood
Complete Eye Care, Hamel
Chu Vision Institute, Bloomington
Ophthalmology Consultants Ltd., St Louis
Tauber Eye Center, Kansas City
Advanced Laser Vision & Surgical Institute, Houston
R and R Eye Research, LLC, San Antonio
The Eye Center of Northern Colorado, Fort Collins
Vision Institute, Colorado Springs
North Valley Eye Medical Group, Inc., Mission Hills
Canyon City EyeCare, Azusa
LoBue Laser and Eye Medical Center, Murrieta
Visionary Eye Institute, Newport Beach
North Bay Eye Associates, Petaluma
Martel Eye Medical Group, Rancho Cordova
Connecticut Eye Consultants, PC, Danbury
Surface Ophthalmics, Inc.
INDUSTRY